Malin Corporation | MLC - Current Assets


Malin Corporation reported EUR62.6M in Current Assets for its fiscal semester ending in December of 2024.





Current Assets Change Date
Akebia Therapeutics USD 258.34M 23.68M Sep/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
ALKERMES USD 1.74B 106.38M Sep/2025
Avita Medical AUD 36.25M 20.75M Jun/2025
Dianthus Therapeutics USD 413.82M 150.22M Sep/2025
Eurofins Scientific SE EUR 2.65B 34.2M Dec/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Lonza CHF 5.44B 113M Dec/2024
Malin Corporation EUR 62.6M 26.7M Dec/2024
Moderna USD 6.54B 54M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Ovoca Bio EUR 4.96M 2.06M Jun/2022
Revvity USD 2.24B 95.96M Dec/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Viatris USD 9.95B 176.8M Sep/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025